Tag: Cancer: Leukemia

Overall survival inferior for acute myeloid leukemia patients with versus without central nervous system involvement

Three-year overall and disease-free survival, three-year cumulative incidence of relapse similar between the groups

Study finds increased risk for cancer overall and for specific cancers for first- and second-degree relatives

Overall survival rates were 29.8 and 21.6 percent five and 10 years after hematopoietic stem cell transplant

Haploidentical stem cell transplantation using nonmyeloablative conditioning regimen effective in highly selected patients

Strongest association seen for benzene exposure and acute myeloid leukemia

Improvement in survival seen with measurable residual disease-directed ibrutinib-venetoclax versus fludarabine-cyclophosphamide-rituximab

Findings seen for patients diagnosed with acute lymphoblastic leukemia and non-Hodgkin lymphoma from the 1970s through the 1990s

Overall survival did not differ, but significant interaction found between supplementation and NPM1 with survival

Risks for therapy-related myelodysplastic syndrome/acute myeloid leukemia elevated, but risks lower in recent years